Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Locally Advanced Hepatocellular Carcinoma · Metastatic Hepatocellular Carcinoma · Stage III Hepatocellular Carcinoma AJCC v8 · Stage IIIA Hepatocellular Carcinoma AJCC v8 · Stage IIIB Hepatocellular Carcinoma AJCC v8 · Stage IV Hepatocellular Carcinoma AJCC v8 · Stage IVA Hepatocellular Carcinoma AJCC v8 · Stage IVB Hepatocellular Carcinoma AJCC v8 · Unresectable Hepatocellular Carcinoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Mayo Clinic in Arizona, Scottsdale, Arizona, United States

    Contact: Study coordinator (Laurie Mihalik) · mihalik.laurie@mayo.edu · 480-342-3256
    Contact: Principal Investigator (Tanios S. Bekaii-Saab)
  • Mayo Clinic in Florida, Jacksonville, Florida, United States

  • Cleveland Clinic Weston Florida, Weston, Florida, United States

  • University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Amanda Spratt) · aspratt@bsd.uchicago.edu · 734-232-0753
    Contact: Principal Investigator (Chih-Yi Liao)
  • Carle Cancer Center NCI Community Oncology Research Program, Urbana, Illinois, United States

    Contact: Study coordinator (Hannah Parks) · Hannah.Parks@Carle.com · 217-326-3150
    Contact: Principal Investigator (Suparna Mantha)
  • University Medical Center New Orleans, New Orleans, Louisiana, United States

    Contact: Study coordinator (Jyostna Fuloira) · juotsna.fuloria@lcmchealth.org · 504-702-4410
    Contact: Principal Investigator (Jyotsna Fuloria)
  • Michigan Cancer Research Consortium NCORP, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Christina Velfing) · christina.velfing@stjoeshealth.org · 734-712-4950
    Contact: Principal Investigator (Elie G. Dib)
  • University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Cindy Rekowski) · crekowsk@med.umich.edu · 734-232-0753
    Contact: Principal Investigator (Oxana V. Crysler)
  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

    Contact: Study coordinator (Katie L Wittenberger) · Wittenberger.Kathleen@mayo.edu
    Contact: Study coordinator (Lori Martinez) · martinez.lori@mayo.edu · 507-293-2335
    Contact: Principal Investigator (Nguyen Tran)
  • Roswell Park Cancer Institute, Buffalo, New York, United States

    Contact: Study coordinator (Deeponpaul Singh) · deeponpaul.singh@roswellpark.org · 716-845-8270
    Contact: Principal Investigator (Renuka V. Iyer)
  • Duke University Medical Center, Durham, North Carolina, United States

  • University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

  • Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Jackie Hahn-Efrati) · jacqueline.hahnefrati@ahn.org · (412) 330-6311
    Contact: Principal Investigator (Dulabh K. Monga)
  • Rapid City Regional Hospital, Rapid City, South Dakota, United States

    Contact: Study coordinator (Angie Dunbar) · adunbar@monument.health · 605-755-2370
    Contact: Principal Investigator (Abdel-Ghani Azzouqa)
  • Froedtert and the Medical College of Wisconsin LAPS, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Dawn Carini) · dcarini@mcw.edu · (414) 805-0789
    Contact: Study coordinator (Marc Casati) · mcasati@mcw.edu · (414) 805-4923
    Contact: Principal Investigator (Aditya Shreenivas)
  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Stacey L. Zindars) · szindars@mcw.edu · 414-805-8913
    Contact: Principal Investigator (Aditya Shreenivas)
מובילי המחקר
  • Wen Wee Ma

    Principal Investigator

    Academic and Community Cancer Research United